Craniocervical chordomas.

Area of Science:

• Neurosurgery
• Oncology
• Radiotherapy

Background:

• Craniocervical chordomas are rare tumors requiring multimodal treatment approaches.
• Complete surgical resection is often impossible, necessitating palliative strategies.

Observation:

• Seven cases treated over 20 years highlight the challenges in managing these tumors.
• Tumor recurrence and metastasis, though infrequent, significantly impact patient outcomes.
• High-dose radiation (≥10,000 rads) may offer long-term survival but risks neurological damage.

Findings:

• Current treatment aims for tumor debulking and postoperative irradiation, primarily for palliation.
• Recurrence necessitates further surgery and radiation, with limited success in altering the tumor's natural history.
• One case demonstrated rapid local recurrence and late distal metastasis, similar to localized forms.

Implications:

• Effective management of craniocervical chordomas remains difficult, with palliation as the main goal.
• Careful consideration of radiation dosage is crucial to balance efficacy and risk of permanent neurological damage.
• Further research into novel therapeutic strategies is warranted for improved outcomes in craniocervical chordoma patients.